Jagsonpal Pharmaceuticals Limited — Updates, 21-01-2026: Press Release
21-01-2026 | 07:09 pm
21-01-2026 | 07:09 pm
Jagsonpal Pharma announced strong Q3 & 9-month results. 9M PAT grew 12.5% to ₹35.9 Cr (Q3 PAT up 10% to ₹12.5 Cr). 9M revenue rose 6% to ₹223 Cr. Company maintains robust ₹175.7 Cr cash balance, expecting stronger Q4 growth ahead.
No comments yet. Be the first to comment!
